サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1532778

腫瘍トランスクリプトミクス市場：製品タイプ別、用途別、技術別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年予測

Tumor Transcriptomics Market, By Product type, By Application, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
腫瘍トランスクリプトミクス市場：製品タイプ別、用途別、技術別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

腫瘍トランスクリプトミクスの市場規模は2023年に57億9,010万米ドルと評価され、2024年から2032年にかけて10.10%のCAGRで拡大

腫瘍トランスクリプトミクス市場 - 市場力学

診断と創薬における研究開発の増加が市場需要を促進

トランスクリプトミクス市場の成長は、診断学と創薬における研究開発の増加、がんや神経筋疾患などの慢性疾患の有病率の上昇、トランスクリプトミクスの応用拡大によって積極的に推進されています。トランスクリプトミクスは、特にがんや糖尿病のような慢性疾患の世界の負担増に伴い、疾患診断を加速する上で重要な役割を果たしています。例えば、GLOBOCAN 2020報告書によると、世界では約1,920万人の新規がん患者が発生し、990万人が死亡しています。このような患者数の増加は、市場成長にプラスの影響を与えると予想されます。市場成長は、主要市場企業の製品発表、事業拡大、提携、買収によって大きく牽引されると予想されます。例えば、2020年2月、Caris Life Sciences社は、Whole Transcriptome Sequencing（WTS）を利用した最新のゲノムプロファイリングオファリング「MI Transcriptome」を発表しました。この技術は、患者の腫瘍の詳細なRNAプロファイリングを可能にし、DNA、RNA、タンパク質を評価するCarisの包括的アプローチを補完し、治療法を正確に調整します。このような上市は市場拡大にプラスの影響を与えると思われます。同様に、2020年2月、Dovetail Genomics社は、Dovetail HiChIPキットとMicro-Cキットを発売し、世界の顧客基盤の拡大と市場成長のさらなる促進を目指しています。

腫瘍トランスクリプトミクス市場 - 主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約10.10%のCAGRで毎年成長すると予測されています。

製品タイプ別セグメンテーションでは、機器が2023年に最大市場シェアを示すと予測されています。

技術セグメンテーションに基づくと、シーケンス技術が2023年に主要なタイプでした。

地域別では、北米が2023年に主要な収益源となりました。

腫瘍トランスクリプトミクス市場 - セグメンテーション分析：

世界の腫瘍トランスクリプトミクス市場は、製品タイプ、用途、技術、地域に基づいて区分されます。

市場は製品タイプに基づいて3つに分類される：消耗品、機器、その他の製品。製品タイプ別では、トランスクリプトーム解析の実施に重要な役割を果たす機器が圧倒的な地位を占めています。マイクロアレイスキャナー、リアルタイム定量PCR装置、次世代シーケンシングプラットフォームなどの機器は、データを生成し、ハイスループットのトランスクリプトーム解析を行うために不可欠です。これらの機器は、疾病メカニズムの解明、バイオマーカーの同定、個別化治療戦略の開発を目指す研究者や臨床医にとって極めて重要であり、市場における優位性を確固たるものにしています。

市場は技術によって3つのカテゴリーに分けられる：マイクロアレイ、リアルタイム定量ポリメラーゼ連鎖反応（Q-PCR）、シーケンス技術です。トランスクリプトミクス市場では、トランスクリプトームを高分解能で解析する高度な機能により、シーケンス技術が技術分野で優位を占めています。RNAシーケンス（RNA-Seq）は、研究者が希少転写産物を検出し、代替スプライシングイベントを調査し、遺伝子発現レベルを正確に定量化できるようにすることで、トランスクリプトーム研究に革命をもたらしました。遺伝子発現プロファイルと分子経路に関する包括的な洞察を提供するこの技術の能力により、研究および臨床アプリケーションの両方で不可欠なものとなり、市場での優位性を牽引しています。

腫瘍トランスクリプトミクス市場 - 地理的洞察

地域的に見ると、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカにまたがる広大な地域をカバーしています。これらの地域内の個々の国が、さらに市場を分類しています。北米は、政府の積極的な取り組み、医療支出の増加、業界リーダーの強固な存在感、高度なヘルスケアインフラ、利用可能なテクノロジーに関する医療利害関係者の意識の高まり、特に米国における市場プレイヤーの高集中などが追い風となり、市場をリードすると予測されています。

腫瘍トランスクリプトミクス市場 - 競合情勢：

腫瘍トランスクリプトミクス市場とは、腫瘍における遺伝子発現パターンの研究・解析に焦点を当てた分野を指します。がん細胞のトランスクリプトームを理解することを目的とした技術や手法が含まれ、腫瘍生物学、疾患の進行、潜在的な治療標的に関する洞察を提供することができます。この市場で企業が採用している主な戦略には、高度なシーケンス技術の開拓、データ共有や臨床試験のための研究機関や製薬会社との協力関係の確立、複雑なゲノムデータを効果的に解釈するためのバイオインフォマティクス能力の強化などがあります。この市場を牽引しているのは、腫瘍学における研究投資の増加、個別化医療へのアプローチ、ゲノム・プロファイリングに基づく標的がん治療への需要の高まりです。トランスクリプトミクス分野の様々な市場参入企業は、疾患診断のための新しい機器や技術の革新に引き続き注力しています。

目次

第1章 腫瘍トランスクリプトミクス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 腫瘍トランスクリプトミクスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 腫瘍トランスクリプトミクス産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 腫瘍トランスクリプトミクス市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 腫瘍トランスクリプトミクス市場情勢

  • 腫瘍トランスクリプトミクス市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 腫瘍トランスクリプトミクス市場 - 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 消耗品
    • 機器
    • その他

第8章 腫瘍トランスクリプトミクス市場 - 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 診断と疾患プロファイリング
    • 創薬
    • その他

第9章 腫瘍トランスクリプトミクス市場 - 技術別

  • 概要
    • 技術別セグメントシェア分析
    • マイクロアレイ
    • リアルタイム定量ポリメラーゼ連鎖反応（Q-PCR）
    • シーケンシング技術

第10章 腫瘍トランスクリプトミクス市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 腫瘍トランスクリプトミクス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • 10x Genomics
    • Agilent Technologies Inc.
    • BGI Genomics
    • Bio-Rad Laboratories Inc.
    • Dovetail Genomics
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • GE Healthcare
    • Illumina Inc.
    • Merck KGaA
    • Natera Inc.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Tumor Transcriptomics Market: Product type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product type
  • TABLE Global Tumor Transcriptomics Market, by Product type 2019-2032 (USD Million)
  • TABLE Tumor Transcriptomics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Tumor Transcriptomics Market, by Application 2019-2032 (USD Million)
  • TABLE Tumor Transcriptomics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Tumor Transcriptomics Market, by Technology 2019-2032 (USD Million)
  • TABLE Tumor Transcriptomics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Tumor Transcriptomics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)

List of Figures

  • FIGURE Tumor Transcriptomics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product type segment market share analysis, 2023 & 2032
  • FIGURE Product type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Technology segment market share analysis, 2023 & 2032
  • FIGURE Technology segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Europe Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Asia Pacific Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Latin America Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Middle East and Africa Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE Germany Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE India Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE Brazil Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE Saudi Arabia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3396

REPORT HIGHLIGHT

Tumor Transcriptomics Market size was valued at USD 5,790.10 Million in 2023, expanding at a CAGR of 10.10% from 2024 to 2032.

Tumor transcriptomics involves analyzing the gene expression profiles of tumors by examining RNA molecules (transcripts). This method identifies genes that are either over-expressed or under-expressed compared to healthy tissue, revealing the molecular characteristics of tumors. This approach offers insights into how tumors develop, progress, and potential targets for treatment. Tumor transcriptomics is crucial for personalized medicine as it allows for the identification of key mutations driving cancer and facilitates the customization of treatment plans based on the specific transcriptional profile of each tumor.

Tumor Transcriptomics Market- Market Dynamics

Increasing research and development in diagnostics and drug discovery to propel market demand

The growth of the transcriptomics market is being actively driven by increasing research and development in diagnostics and drug discovery, the rising prevalence of chronic diseases like cancer and neuromuscular disorders, and expanding applications of transcriptomics. Transcriptomics plays a crucial role in accelerating disease diagnostics, especially with the growing global burden of chronic diseases such as cancer and diabetes. For example, according to the GLOBOCAN 2020 report, there were approximately 19.2 million new cancer cases and 9.9 million cancer deaths worldwide. This increasing patient population is expected to positively impact market growth. The market growth is anticipated to be significantly driven by product launches, expansions, collaborations, and acquisitions from key market players. For example, in February 2020, Caris Life Sciences introduced its latest genomic profiling offering, MI Transcriptome, which utilizes Whole Transcriptome Sequencing (WTS). This technology enables detailed RNA profiling of patients' tumors, complementing Caris' comprehensive approach that assesses DNA, RNA, and proteins to tailor therapies accurately. Such launches are poised to positively impact market expansion. Similarly, in February 2020, Dovetail Genomics expanded its global reach with the availability of Dovetail HiChIP and Micro-C Kits, aiming to broaden its customer base worldwide and further stimulate market growth.

Tumor Transcriptomics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.10% over the forecast period (2024-2032)

Based on Product type segmentation, instruments was predicted to show maximum market share in the year 2023

Based on technology segmentation, sequencing technologies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Tumor Transcriptomics Market- Segmentation Analysis:

The Global Tumor Transcriptomics Market is segmented on the basis of Product type, Application, Technology, and Region.

The market is divided into three categories based on Product type: Consumables, Instruments, and Other Products. In terms of product types, instruments hold a dominant position due to their critical role in conducting transcriptomic analyses. Instruments such as microarray scanners, real-time quantitative PCR machines, and next-generation sequencing platforms are essential for generating data and performing high-throughput transcriptome analysis. These instruments are pivotal for researchers and clinicians seeking to understand disease mechanisms, identify biomarkers, and develop personalized treatment strategies, thereby solidifying their dominance in the market.

The market is divided into three categories based on technology: Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR) and Sequencing Technologies. In the transcriptomics market, sequencing technologies dominate the technology segment due to their advanced capabilities in analyzing the transcriptome with high resolution. RNA sequencing (RNA-Seq) has revolutionized transcriptomic studies by allowing researchers to detect rare transcripts, study alternative splicing events, and quantify gene expression levels accurately. This technology's ability to provide comprehensive insights into gene expression profiles and molecular pathways has made it indispensable in both research and clinical applications, driving its dominance in the market.

Tumor Transcriptomics Market- Geographical Insights

From a territorial perspective, this market covers a vast geographic area, stretching across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Individual countries within these regions create further market classifications. North America is projected to lead the market, fueled by favorable government initiatives, rising healthcare spending, a robust presence of industry leaders, advanced healthcare infrastructure, heightened awareness among healthcare stakeholders about available technologies, and a high concentration of market players, particularly in the United States.

Tumor Transcriptomics Market- Competitive Landscape:

The Tumor Transcriptomics market refers to the sector focused on the study and analysis of gene expression patterns in tumors. It involves technologies and methodologies aimed at understanding the transcriptome of cancer cells, which can provide insights into tumor biology, disease progression, and potential therapeutic targets. Key strategies adopted by companies in this market include developing advanced sequencing technologies, establishing collaborations with research institutions and pharmaceutical companies for data sharing and clinical trials, and enhancing bioinformatics capabilities to interpret complex genomic data effectively. The market is driven by increasing research investments in oncology, personalized medicine approaches, and the growing demand for targeted cancer therapies based on genomic profiling. Various market participants in the transcriptomics sector continue to focus on innovating new instruments and techniques for disease diagnostics.

Recent Developments:

In August 2021, HTG Molecular Diagnostics, Inc. launched its HTG Transcriptome Panel in the U.S. and Europe. This panel, utilizing HTG EdgeSeq technology, can measure nearly 20,000 mRNA targets and has demonstrated repeatability for diagnosing multiple cancers. These advancements and launches are expected to bolster growth within this segment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUMOR TRANSCRIPTOMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

10x Genomics

Agilent Technologies Inc.

BGI Genomics

Bio-Rad Laboratories Inc.

Dovetail Genomics

F. Hoffmann-La Roche AG

Fluidigm Corporation

GE Healthcare

Illumina Inc.

Merck KGaA

Natera Inc.

Others

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Consumables
  • Instruments
  • Other Products

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diagnostics and Disease Profiling
  • Drug Discovery
  • Other Applications

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Microarray
  • Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
  • Sequencing Technologies

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tumor Transcriptomics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tumor Transcriptomics Market Snippet by Product type
    • 2.1.2. Tumor Transcriptomics Market Snippet by Application
    • 2.1.3. Tumor Transcriptomics Market Snippet by Technology
    • 2.1.4. Tumor Transcriptomics Market Snippet by Country
    • 2.1.5. Tumor Transcriptomics Market Snippet by Region
  • 2.2. Competitive Insights

3. Tumor Transcriptomics Key Market Trends

  • 3.1. Tumor Transcriptomics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tumor Transcriptomics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tumor Transcriptomics Market Opportunities
  • 3.4. Tumor Transcriptomics Market Future Trends

4. Tumor Transcriptomics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tumor Transcriptomics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tumor Transcriptomics Market Landscape

  • 6.1. Tumor Transcriptomics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tumor Transcriptomics Market - By Product type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product type, 2023 & 2032 (%)
    • 7.1.2. Consumables
    • 7.1.3. Instruments
    • 7.1.4. Other Products

8. Tumor Transcriptomics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diagnostics and Disease Profiling
    • 8.1.3. Drug Discovery
    • 8.1.4. Other Applications

9. Tumor Transcriptomics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 9.1.2. Microarray
    • 9.1.3. Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
    • 9.1.4. Sequencing Technologies

10. Tumor Transcriptomics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Tumor Transcriptomics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Tumor Transcriptomics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Tumor Transcriptomics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Tumor Transcriptomics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Tumor Transcriptomics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Tumor Transcriptomics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 10x Genomics
    • 11.2.2. Agilent Technologies Inc.
    • 11.2.3. BGI Genomics
    • 11.2.4. Bio-Rad Laboratories Inc.
    • 11.2.5. Dovetail Genomics
    • 11.2.6. F. Hoffmann-La Roche AG
    • 11.2.7. Fluidigm Corporation
    • 11.2.8. GE Healthcare
    • 11.2.9. Illumina Inc.
    • 11.2.10. Merck KGaA
    • 11.2.11. Natera Inc.
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us